Cochrane Abstracts
High‐dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"High‐dose Chemotherapy and Autologous Bone Marrow or Stem Cell Transplantation Versus Conventional Chemotherapy for Women With Early Poor Prognosis Breast Cancer." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432830/all/High‐dose_chemotherapy_and_autologous_bone_marrow_or_stem_cell_transplantation_versus_conventional_chemotherapy_for_women_with_early_poor_prognosis_breast_cancer_Stable__no_update_expected_for_reasons_given_in_'What's_new'_. Accessed 08 December 2023.
High‐dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432830/all/High‐dose_chemotherapy_and_autologous_bone_marrow_or_stem_cell_transplantation_versus_conventional_chemotherapy_for_women_with_early_poor_prognosis_breast_cancer_Stable__no_update_expected_for_reasons_given_in_'What's_new'_. Accessed December 8, 2023.
High‐dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432830/all/High‐dose_chemotherapy_and_autologous_bone_marrow_or_stem_cell_transplantation_versus_conventional_chemotherapy_for_women_with_early_poor_prognosis_breast_cancer_Stable__no_update_expected_for_reasons_given_in_'What's_new'_
High‐dose Chemotherapy and Autologous Bone Marrow or Stem Cell Transplantation Versus Conventional Chemotherapy for Women With Early Poor Prognosis Breast Cancer [Internet]. In: Cochrane Abstracts. [cited 2023 December 08]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432830/all/High‐dose_chemotherapy_and_autologous_bone_marrow_or_stem_cell_transplantation_versus_conventional_chemotherapy_for_women_with_early_poor_prognosis_breast_cancer_Stable__no_update_expected_for_reasons_given_in_'What's_new'_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - High‐dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer
ID - 432830
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432830/all/High‐dose_chemotherapy_and_autologous_bone_marrow_or_stem_cell_transplantation_versus_conventional_chemotherapy_for_women_with_early_poor_prognosis_breast_cancer_Stable__no_update_expected_for_reasons_given_in_'What's_new'_
DB - Evidence Central
DP - Unbound Medicine
ER -
